Last reviewed · How we verify
NCT06654102
A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure
NA trial testing Deep UVA Irradiation in Skin Pigmentation in 18 participants. Completed in 26 November 2024.
26 November 2024
Quick facts
| Lead sponsor | Johnson & Johnson Consumer Inc. (J&JCI) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 18 |
| Start date | 23 October 2024 |
| Primary completion | 26 November 2024 |
| Estimated completion | 26 November 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Deep UVA Irradiation
- Deep UVA+HEV Blue Light Irradiation
Conditions studied
- Skin Pigmentation — all drugs for Skin Pigmentation →
- Photobiology — all drugs for Photobiology →
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI) — full company profile →
Who can join
Adults 18 to 60, female only, with Skin Pigmentation or Photobiology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to assess the level of pigmentation following an acute exposure of skin to light regimens representative of portions of the natural sunlight spectrum and that contain Deep UVA wavelengths with or without HEV Blue Light, as compared to non-irradiated control skin.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06654102
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Pigmentation
Currently open trials in the same condition.
- NCT06869252 — Autologous Adipose Cells Therapy · Phase 1, PHASE2 · recruiting
- NCT06142019 — Pulse Oximeter Accuracy in Healthy Humans During Hypoxia · recruiting
- NCT04875715 — Prospective Evaluation of Topical Almond Oil vs Hydroquinone · Phase 4 · recruiting
Other Johnson & Johnson Consumer Inc. (J&JCI) trials
Trials by the same sponsor.
- NCT06852742 — A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged Skin · NA · completed
- NCT06734299 — A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin Tones · NA · completed
- NCT06658847 — A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Us · NA · completed
- NCT06318637 — Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates · NA · completed
- NCT05845008 — A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain · Phase 3 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06654102 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Consumer Inc. (J&JCI)
- Last refreshed: 11 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06654102.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing